文献速递甲状腺疾病

预测高分化甲状腺癌患者生存结局的临床列线图

A Clinical Nomogram to Predict Survival Outcomes in Patients with Well-Differentiated Thyroid Cancer.
PubMed 文献 · Thyroid · 2025-02-14

本研究基于纪念斯隆凯特琳癌症中心8535例接受初次手术的高分化甲状腺癌患者,回顾性构建以性别、年龄、病理亚型和TNM分期为变量的疾病特异性生存列线图,内部一致性指数为0.963(SE 0.012);在3个国际中心519例外部队列中验证,一致性指数为0.810(SE 0.070)。该列线图有助于个体化预后咨询,并可能识别可从更积极治疗中获益的患者。

要点

  • 列线图基于8535例高分化甲状腺癌患者构建,预测疾病特异性生存。
  • 内部一致性指数0.963(SE 0.012),外部验证一致性指数0.810(SE 0.070)。
  • 性别、年龄、病理亚型、TNM分期均为疾病特异性生存的显著预测因素。

核心结论

  • 作者描述了一种能准确预测高分化甲状腺癌患者个体疾病特异性生存的列线图,外部验证显示其具有可推广性,有助于个体化预后咨询并可能识别可从更积极治疗中获益的患者。

研究设计与样本

  • 回顾性队列研究,使用纪念斯隆凯特琳癌症中心单中心8535例接受初次手术的高分化甲状腺癌患者构建列线图。
  • 外部队列来自3个不同国际中心的519例患者,用于评估列线图的准确性和可推广性。

主要发现

  • 单因素分析中,性别、年龄、病理亚型、T分期、N分期和M分期均为疾病特异性生存的显著预测因素。
  • 使用上述所有变量构建的列线图内部一致性指数为0.963(SE 0.012)。
  • 外部队列验证的一致性指数为0.810(SE 0.070)。

关键数值与推荐

  • 列线图以疾病特异性生存为因变量,纳入的自变量为性别、年龄、病理亚型和TNM分期。

临床怎么用

  • 作者认为该列线图有助于个体化预后咨询,并可能识别可从更积极治疗中获益的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The current American Joint Committee on Cancer 8th edition staging system on thyroid cancer describes outcomes for populations of patients with well-differentiated thyroid cancer (WDTC) and not individual patients. The aim of this study was to create a clinical nomogram that can be used to predict survival in individual patients with WDTC. Methods: A single institutional cohort of 8535 patients with WDTC treated with primary surgery at the Memorial Sloan Kettering Cancer Center was used to create a predictive nomogram for disease-specific survival (DSS) as a retrospective cohort study. The nomogram was created using DSS as the dependent variable, and the independent variables used were sex, age, pathology subtype, and TNM stage. An external validation cohort of 519 patients from three different international centers was used to assess the accuracy and generalizability of the nomogram. Results: Sex, age, pathology subtype, T stage, N stage, and M stage were significant predictors of DSS on univariable analysis. The nomogram created using all these variables showed an extremely high concordance index (0.963; SE 0.012). This nomogram was validated on the external patient cohort with a high concordance index (0.810; SE: 0.070). Conclusions: We describe a predictive nomogram that accurately predicts DSS in individual patients with WDTC. The external validation illustrates its generalizability. This nomogram will help in counseling individual patients on prognosis and may identify patients who could benefit from more aggressive therapy.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Valero C, Eagan A, Adilbay D, et al. A Clinical Nomogram to Predict Survival Outcomes in Patients with Well-Differentiated Thyroid Cancer. Thyroid. 2025. PMID: 39951725. doi:10.1089/thy.2024.0486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。